Duygu Has Şimşek

769 total citations
58 papers, 527 citations indexed

About

Duygu Has Şimşek is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Duygu Has Şimşek has authored 58 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Duygu Has Şimşek's work include Radiopharmaceutical Chemistry and Applications (16 papers), Prostate Cancer Treatment and Research (16 papers) and Peptidase Inhibition and Analysis (13 papers). Duygu Has Şimşek is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (16 papers), Prostate Cancer Treatment and Research (16 papers) and Peptidase Inhibition and Analysis (13 papers). Duygu Has Şimşek collaborates with scholars based in Türkiye, United States and Iran. Duygu Has Şimşek's co-authors include Yasemin Şanlı, Serkan Kuyumcu, Cüneyt Türkmen, Emine Göknur Işık, Zeynep Gözde Özkan, Seher Ünal, İşık Adalet, Öner Şanlı, Nuri Faruk Aykan and Meltem Ekenel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Duygu Has Şimşek

54 papers receiving 517 citations

Peers

Countries citing papers authored by Duygu Has Şimşek

Since Specialization

Citations

This map shows the geographic impact of Duygu Has Şimşek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duygu Has Şimşek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duygu Has Şimşek more than expected).

Fields of papers citing papers by Duygu Has Şimşek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duygu Has Şimşek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duygu Has Şimşek. The network helps show where Duygu Has Şimşek may publish in the future.

Co-authorship network of co-authors of Duygu Has Şimşek

This figure shows the co-authorship network connecting the top 25 collaborators of Duygu Has Şimşek. A scholar is included among the top collaborators of Duygu Has Şimşek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duygu Has Şimşek. Duygu Has Şimşek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer 2024 ·Clinical Nuclear Medicine ·Emine Göknur Işık, Duygu Has Şimşek, Nurdan Gül, Şükrü Mehmet Ertürk, (unknown), (unknown), (unknown), Zeynep Gözde Özkan, Yasemin Şanlı, Ayşe Mudun, Serkan Kuyumcu	2
2	The Role of [ ¹⁸ F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage 2024 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Zeynep Gözde Özkan, Berker Özkan, Emine Göknur Işık, (unknown), Duygu Has Şimşek, (unknown), Yasemin Şanlı, (unknown), Serkan Kuyumcu, Alper Toker	1
3	68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Serkan Kuyumcu, (unknown), Duygu Has Şimşek, Arzu Poyanlı, Ayşe Kubat Üzüm, (unknown), Emine Göknur Işık, Semen Önder, Nihat Aksakal, Zeynep Gözde Özkan, Yasemin Şanlı	9
4	Combination of 68Ga-FAPI-04 and Dedicated Breast PET (MAMMI PET) Outperformed Breast MRI and 18F-FDG PET/CT by Revealing Nipple and Skin Involvement of Breast Cancer 2024 ·Clinical Nuclear Medicine ·Duygu Has Şimşek, (unknown), (unknown), Mustafa Tükenmez, Serkan Kuyumcu	2
5	Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on ⁹⁰ Y Selective Internal Radiation Therapy Planning 2024 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), (unknown), (unknown), Serkan Kuyumcu, Emine Göknur Işık, Duygu Has Şimşek, Zeynep Gözde Özkan, Arzu Poyanlı, (unknown), Yasemin Şanlı	0
6	Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy 2024 ·World Journal of Surgical Oncology ·(unknown), (unknown), Neslihan Cabıoğlu, (unknown), Mustafa Tükenmez, Hasan Karanlık, Tolga Özmen, Ravza Yılmaz, (unknown), Semen Önder, (unknown), Duygu Has Şimşek, (unknown), (unknown), Adnan Aydıner, Vahit Özmen, Abdullah İğci	4
7	The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Duygu Has Şimşek, Yunus Güzel, (unknown), Yasemin Şanlı, (unknown), (unknown), Halil Kömek, Emine Göknur Işık, Zeynep Gözde Özkan, Serkan Kuyumcu	4
8	Influencing factors of lung shunt fraction in transarterial radioembolization treatment 2023 ·Clinical and Translational Imaging ·(unknown), (unknown), Emine Göknur Işık, Duygu Has Şimşek, Zeynep Gözde Özkan, (unknown), Yasemin Şanlı, (unknown), Serkan Kuyumcu	2
9	The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Serkan Kuyumcu, Duygu Has Şimşek, Öner Şanlı, Emine Göknur Işık, Zeynep Gözde Özkan, (unknown), Yasemin Şanlı	15
10	Utility of 68Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18F-FDG PET/CT 2023 ·Clinical Nuclear Medicine ·(unknown), Emine Göknur Işık, Duygu Has Şimşek, (unknown), Serkan Kuyumcu	4
11	FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT 2023 ·Clinical Nuclear Medicine ·(unknown), Duygu Has Şimşek, Emine Göknur Işık, Yasemin Şanlı, Serkan Kuyumcu	7
12	THE IMPACT OF 68GA-PSMA PET/CT ON THERAPY MANAGEMENT OF HIGH RISK PROSTATE CANCER 2021 ·SHILAP Revista de lepidopterología ·Duygu Has Şimşek, Emine Göknur Işık, (unknown), Zeynep Gözde Özkan, Serkan Kuyumcu, (unknown), (unknown), Yasemin Şanlı	1
13	Demonstration of in vivo estrogen receptor status with 16α- [18F]fluoro-17ß-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Duygu Has Şimşek, Serkan Kuyumcu, Zeynep Gözde Özkan, (unknown), (unknown), Samet Topuz, Adnan Aydıner, Yasemin Şanlı	5
14	Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up 2021 ·Annals of Nuclear Medicine ·Zeynep Gözde Özkan, Duygu Has Şimşek, Serkan Kuyumcu, (unknown), Emine Göknur Işık, (unknown), Senem Karabulut, Yasemin Şanlı	1
15	An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 ( ¹⁷⁷ Lu)-DOTATATE 2021 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Zeynep Gözde Özkan, (unknown), (unknown), Emine Göknur Işık, Duygu Has Şimşek, (unknown), Cüneyt Türkmen, Yasemin Şanlı	5
16	Somatostatin receptor-positive breast lesions on 68Ga-DOTATATE PET/CT 2021 ·Annals of Nuclear Medicine ·Duygu Has Şimşek, Emine Göknur Işık, (unknown), Serkan Kuyumcu, Ayşe Mudun, Yasemin Şanlı	2
17	The diagnostic accuracy of Ga68 PSMA PET-CT on clinical lymph node staging before radical prostatectomy in patients with intermediate or high risk prostate cancer 2020 ·European Urology Open Science ·Selçuk Erdem, Duygu Has Şimşek, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Faruk Özcan	0
18	PET/CT Findings of a Patient with Cardiac Metastasis of Subungual Malign Melanoma 2019 ·Molecular Imaging and Radionuclide Therapy ·Özgül Ekmekçioğlu, (unknown), (unknown), Nihal Kaplan, (unknown), Duygu Has Şimşek, Şükrü Mehmet Ertürk	2
19	68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas 2018 ·Annals of Nuclear Medicine ·Duygu Has Şimşek, Yasemin Şanlı, Serkan Kuyumcu, Bora Başaran, Ayşe Mudun	8
20	Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer 2012 ·Nuclear Medicine Communications ·Yasemin Şanlı, Cüneyt Türkmen, Barış Bakır, Cem İyibozkurt, Sevda Özel, Duygu Has Şimşek, Ebru Yılmaz, Samet Topuz, Ekrem Yavuz, Seher Ünal, Ayşe Mudun	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact